tiprankstipranks
Agios Pharma (MX:AGIO)
:AGIO
Mexico Market
AGIO
Agios Pharma
RESEARCH TOOLSreports

Agios Pharma (AGIO) Ratios

1 Followers

Agios Pharma Ratios

MX:AGIO's free cash flow for Q2 2026 was $0.93. For the 2026 fiscal year, MX:AGIO's free cash flow was decreased by $ and operating cash flow was $-2.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 10.22 11.46 11.90 12.27 13.30
Quick Ratio
 9.79 11.06 11.56 11.99 13.16
Cash Ratio
 1.42 1.08 0.94 1.30 2.22
Solvency Ratio
 -4.93 -3.92 5.56 -2.74 -1.62
Operating Cash Flow Ratio
 -5.14 -4.54 -4.80 -4.36 -4.94
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 635.26M$ 837.94M$ 843.36M$ 707.74M$ 694.87M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.08 0.07
Debt-to-Equity Ratio
 0.03 0.03 0.04 0.09 0.08
Debt-to-Capital Ratio
 0.03 0.03 0.04 0.08 0.07
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.08 1.09 1.08 1.16 1.13
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.52 0.69 1.00 1.29 1.56
Net Debt to EBITDA
 0.16 0.12 -0.03 0.04 0.14
Profitability Margins
Gross Profit Margin
87.92%78.67%88.59%64.57%88.03%
EBIT Margin
-429.29%-765.89%1967.15%-1459.52%-2732.07%
EBITDA Margin
-423.84%-756.31%1982.63%-1434.83%-2671.93%
Operating Profit Margin
-466.78%-873.87%-1166.47%-1459.52%-2732.07%
Pretax Profit Margin
-419.27%-765.89%1967.15%-1312.63%-1627.82%
Net Profit Margin
-418.24%-764.01%1845.92%-1312.63%-1627.82%
Continuous Operations Profit Margin
-418.24%-764.01%1845.92%-1312.63%-1627.82%
Net Income Per EBT
99.75%99.75%93.84%100.00%100.00%
EBT Per EBIT
89.82%87.64%-168.64%89.94%59.58%
Return on Assets (ROA)
-37.11%-31.82%40.51%-37.57%-18.71%
Return on Equity (ROE)
-35.67%-34.60%43.72%-43.41%-21.06%
Return on Capital Employed (ROCE)
-44.21%-38.86%-26.91%-45.04%-33.08%
Return on Invested Capital (ROIC)
-43.30%-38.18%-24.99%-44.28%-32.70%
Return on Tangible Assets
-37.11%-31.82%40.51%-37.57%-18.71%
Earnings Yield
-20.89%-26.16%36.09%-28.41%-15.07%
Efficiency Ratios
Receivables Turnover
 4.89 5.11 8.88 9.55 6.46
Payables Turnover
 0.73 0.63 0.25 0.97 0.09
Inventory Turnover
 0.39 0.35 0.15 0.50 0.20
Fixed Asset Turnover
 9.89 1.31 0.67 0.38 0.16
Asset Turnover
 0.09 0.04 0.02 0.03 0.01
Working Capital Turnover Ratio
 0.14 0.06 0.04 0.03 0.02
Cash Conversion Cycle
 499.00 532.85 1.00K 395.25 -2.11K
Days of Sales Outstanding
 74.65 71.46 41.09 38.24 56.54
Days of Inventory Outstanding
 926.70 1.04K 2.42K 732.61 1.82K
Days of Payables Outstanding
 502.35 581.46 1.46K 375.60 3.99K
Operating Cycle
 1.00K 1.11K 2.46K 770.85 1.88K
Cash Flow Ratios
Operating Cash Flow Per Share
 -6.06 -6.43 -6.86 -5.32 -5.65
Free Cash Flow Per Share
 -6.14 -6.51 -6.89 -5.34 -5.74
CapEx Per Share
 0.08 0.07 0.03 0.02 0.09
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 -77.45 -86.42 -231.36 -296.36 -63.40
Capital Expenditure Coverage Ratio
 -77.45 -86.42 -231.36 -296.36 -63.40
Operating Cash Flow Coverage Ratio
 -11.57 -9.28 -6.84 -4.11 -3.61
Operating Cash Flow to Sales Ratio
 -3.67 -6.90 -10.68 -11.04 -21.73
Free Cash Flow Yield
-18.48%-23.91%-20.97%-23.97%-20.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.72 -3.82 2.77 -3.52 -6.64
Price-to-Sales (P/S) Ratio
 20.10 29.21 51.14 46.21 108.04
Price-to-Book (P/B) Ratio
 1.92 1.32 1.21 1.53 1.40
Price-to-Free Cash Flow (P/FCF) Ratio
 -5.41 -4.18 -4.77 -4.17 -4.89
Price-to-Operating Cash Flow Ratio
 -5.46 -4.23 -4.79 -4.19 -4.97
Price-to-Earnings Growth (PEG) Ratio
 0.03 0.02 >-0.01 -0.07 0.20
Price-to-Fair Value
 1.92 1.32 1.21 1.53 1.40
Enterprise Value Multiple
 -4.58 -3.74 2.55 -3.18 -3.90
Enterprise Value
 1.91B 1.53B 1.85B 1.22B 1.48B
EV to EBITDA
 -4.58 -3.74 2.55 -3.18 -3.90
EV to Sales
 19.40 28.30 50.62 45.60 104.28
EV to Free Cash Flow
 -5.22 -4.05 -4.72 -4.12 -4.72
EV to Operating Cash Flow
 -5.29 -4.10 -4.74 -4.13 -4.80
Tangible Book Value Per Share
 17.25 20.58 27.13 14.57 20.09
Shareholders’ Equity Per Share
 17.25 20.58 27.13 14.57 20.09
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 0.06 0.00 0.00
Revenue Per Share
 1.65 0.93 0.64 0.48 0.26
Net Income Per Share
 -6.91 -7.12 11.86 -6.33 -4.23
Tax Burden
 1.00 1.00 0.94 1.00 1.00
Interest Burden
 0.98 1.00 1.00 0.90 0.60
Research & Development to Revenue
 3.59 6.19 8.25 10.77 19.66
SG&A to Revenue
 1.96 3.34 4.30 0.00 0.00
Stock-Based Compensation to Revenue
 0.59 0.97 1.17 1.67 3.46
Income Quality
 0.88 0.90 -0.58 0.84 1.34
Currency in USD